Page last updated: 2024-09-05

zm 241385 and sulfites

zm 241385 has been researched along with sulfites in 1 studies

Compound Research Comparison

Studies (zm 241385)	Trials (zm 241385)	Recent Studies (post-2010) (zm 241385)	Studies (sulfites)	Trials (sulfites)	Recent Studies (post-2010) (sulfites)
401	3	124	5,901	57	1,669

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bruzzese, L; By, Y; Condo, J; Durand-Gorde, JM; Fenouillet, E; Fromonot, J; Guieu, R; Kipson, N; Ruf, J	1

Other Studies

1 other study(ies) available for zm 241385 and sulfites

Article	Year
NF-κB enhances hypoxia-driven T-cell immunosuppression via upregulation of adenosine A(2A) receptors. Cellular signalling, 2014, Volume: 26, Issue:5 Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Cell Hypoxia; Cell Survival; Cells, Cultured; Cobalt; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunosuppression Therapy; Isoquinolines; NF-kappa B; Receptor, Adenosine A2A; Signal Transduction; Sulfites; Sulfonamides; T-Lymphocytes; Triazines; Triazoles; Up-Regulation	2014

Article

Year

NF-κB enhances hypoxia-driven T-cell immunosuppression via upregulation of adenosine A(2A) receptors.

Cellular signalling, 2014, Volume: 26, Issue:5

Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Cell Hypoxia; Cell Survival; Cells, Cultured; Cobalt; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunosuppression Therapy; Isoquinolines; NF-kappa B; Receptor, Adenosine A2A; Signal Transduction; Sulfites; Sulfonamides; T-Lymphocytes; Triazines; Triazoles; Up-Regulation

2014